MedTrace Logo

A Study of Cabergoline for the Treatment of Cocaine Dependence - 1

NCT00033111 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to assess cabergoline for the Treatment of Cocaine Dependence

Conditions

  • Cocaine-Related Disorders
  • Substance-Related Disorders

Interventions

DRUG

Cabergoline

DRUG

Placebo

sugar pill manufactured to mimic cabergoline 05mg tablet

Sponsors & Collaborators

Principal Investigators

  • Steve Shoptaw, Ph.D. · Friends Research Institute, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-06-30
Completion
2004-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00033111 on ClinicalTrials.gov